苯磺酸氨氯地平与厄贝沙坦治疗老年原发性高血压的成本-效果分析  

Cost-Effectiveness Analysis of Amlodipine Benzene Late Versus Irbesartan for Essential Hypertension in the Elderly

作　　者：孙运慧 SUN Yun-hui(Department of Internal Medicine,Maoxian Maternal and Child Health Hospital,Maoxian County,Aba Sichuan 623200,China)

机构地区：[1]茂县妇幼保健院内科,四川阿坝623200

出　　处：《中华养生保健》2025年第8期177-180,共4页CHINESE HEALTH CARE

摘　　要：目的分析厄贝沙坦与苯磺酸氨氯地平治疗老年原发性高血压的成本-效果。方法纳入2023年9月—2024年7月茂县妇幼保健院收治的70例原发性高血压老年患者为研究对象,通过随机数表法将患者分为两组,每组35例,分别予以苯磺酸氨氯地平以及厄贝沙坦口服治疗。比较两组治疗效果、治疗前后血压改变情况、治疗成本及不良反应发生情况。结果苯磺酸氨氯地平组总有效率与厄贝沙坦组比较,差异无统计学意义(P>0.05);治疗8周后,两组收缩压、舒张压、平均动脉压均低于治疗前,且苯磺酸氨氯地平组低于厄贝沙坦组,差异均具有统计学意义(P<0.05);苯磺酸氨氯地平组直接成本、日均费用均低于厄贝沙坦组,差异均具有统计学意义(P<0.05);苯磺酸氨氯地平组的成本效益比(C/E)优于厄贝沙坦组,差异具有统计学意义(P<0.05);苯磺酸氨氯地平组不良反应总发生率与厄贝沙坦组比较,差异无统计学意义(P>0.05)。结论苯磺酸氨氯地平在治疗老年原发性高血压方面与厄贝沙坦具有相似的治疗效果,且安全性较好,但在降低血压、减少治疗成本和提高成本效果比方面表现更优。Objective To analyze the cost-effectiveness of irbesartan and amlodipine besylate in the treatment of essential hypertension in the elderly.Methods A total of 70 elderly patients with essential hypertension admitted to our hospital between September 2023 and July 2024 were included in this study.The patients were divided into two groups by the random number table method,with 35 people in each group,who were given oral treatment of amlodipine besylate and irbesartan respectively.The treatment effect,blood pressure changes before and after treatment,treatment cost and the occurrence of adverse eff ects were compared between the two groups.Results Amlodipine benzlate group was compared with irbesartan group(P>0.05).After 8 weeks of treatment,systolic,diastolic and mean arterial pressure in both groups were lower than before treatment,and amlodipine benzene late group was lower than irbesartan group(P<0.05).The direct cost of amlodipine group and average daily cost were lower than RMB(P<0.05).The C/E in the amlodipine benzlate group was better than that in the irbesartan group.The overall incidence of adverse eff ects in the amlodipine phenlate group and irbesartan group(P>0.05).Conclusion Amlodipine benzene late has similar therapeutic effect to irbesartan in treating essential hypertension in the elderly,but better performance in reducing blood pressure,reducing treatment cost and improving cost-eff ectiveness ratio.

关 键 词：苯磺酸氨氯地平 厄贝沙坦 老年原发性高血压 成本-效果 

分 类 号：R544.1[医药卫生—心血管疾病]